2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine
C88H86F9N15O — CID 163638198
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine
2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine (PubChem CID 163638198) has the molecular formula C88H86F9N15O and a molecular weight of 1540.74 g/mol. Its IUPAC name is 2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine.
Molecular Properties
| Compound Name | 2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine |
|---|---|
| PubChem CID | 163638198 |
| Molecular Formula | C88H86F9N15O |
| Molecular Weight | 1540.74 g/mol |
| Exact Mass | 1539.70 |
| IUPAC Name | 2-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-1-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]ethanone;1-methyl-4-[[4-[2-[4-methyl-3-[2-(3-methylimidazol-4-yl)ethynyl]phenyl]prop-2-enyl]-2-(trifluoromethyl)phenyl]methyl]piperazine;3-[2-[3-[3-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]prop-1-en-2-yl]phenyl]ethyl]imidazo[1,2-b]pyridazine |
| SMILES | C=C(Cc1ccc(CN2CCN(C)CC2)c(C(F)(F)F)c1)c1ccc(C)c(C#Cc2cncn2C)c1.C=C(Cc1ccc(CN2CCN(C)CC2)c(C(F)(F)F)c1)c1cccc(CCc2cnc3cccnn23)c1.Cc1cn(-c2cc(CC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1 |
| InChI | InChI=1S/C30H32F3N5.C29H23F3N6O.C29H31F3N4/c1-22(25-6-3-5-23(18-25)9-11-27-20-34-29-7-4-12-35-38(27)29)17-24-8-10-26(28(19-24)30(31,32)33)21-37-15-13-36(2)14-16-37;1-18-5-6-21(13-26(18)37-28-34-9-7-25(36-28)22-4-3-8-33-15-22)27(39)12-20-10-23(29(30,31)32)14-24(11-20)38-16-19(2)35-17-38;1-21-5-7-25(17-24(21)9-10-27-18-33-20-35(27)4)22(2)15-23-6-8-26(28(16-23)29(30,31)32)19-36-13-11-34(3)12-14-36/h3-8,10,12,18-20H,1,9,11,13-17,21H2,2H3;3-11,13-17H,12H2,1-2H3,(H,34,36,37);5-8,16-18,20H,2,11-15,19H2,1,3-4H3 |
| InChIKey | IBZSGNHMRKTJFQ-UHFFFAOYSA-N |
| XLogP | 17.22 |
| TPSA | 146.56 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 16 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 113 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1540.74 |
| LogP ≤ 5 | 17.22 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 16 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163638198 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.